Holdings (Monthly)
Guide ↗
Select Pharmaceuticals Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY and CO | 532457108 | Feb 2026 | 362,801 | $381.7M | 25.18% | EC |
| 2 | GSK PLC | 37733W204 | Feb 2026 | 2,581,360 | $152.6M | 10.07% | EC |
| 3 | JOHNSON and JOHNSON | 478160104 | Feb 2026 | 459,700 | $114.2M | 7.53% | EC |
| 4 | UCB SA | N/A | Feb 2026 | 254,500 | $75.9M | 5.01% | EC |
| 5 | ROCHE HOLDING AG | N/A | Feb 2026 | 157,090 | $74.8M | 4.93% | EC |
| 6 | ASTRAZENECA PLC | N/A | Feb 2026 | 358,250 | $74.7M | 4.93% | EC |
| 7 | GILEAD SCIENCES INC | 375558103 | Feb 2026 | 472,500 | $70.4M | 4.64% | EC |
| 8 | MERCK and CO INC | 58933Y105 | Feb 2026 | 561,536 | $69.5M | 4.59% | EC |
| 9 | ELANCO ANIMAL HEALTH INC | 28414H103 | Feb 2026 | 2,536,200 | $67.0M | 4.42% | EC |
| 10 | Fidelity Revere Street Trust | 31635A303 | Feb 2026 | 64,528,911 | $64.5M | 4.26% | STIV |
| 11 | LEGEND BIOTECH CORP | 52490G102 | Feb 2026 | 2,598,400 | $49.4M | 3.26% | EC |
| 12 | JAZZ PHARMACEUTICALS PLC | N/A | Feb 2026 | 227,700 | $43.3M | 2.85% | EC |
| 13 | MODERNA INC | 60770K107 | Feb 2026 | 688,800 | $36.9M | 2.43% | EC |
| 14 | ROYALTY PHARMA PLC | N/A | Feb 2026 | 750,500 | $34.7M | 2.29% | EC |
| 15 | VIATRIS INC | 92556V106 | Feb 2026 | 1,729,600 | $25.8M | 1.70% | EC |
| 16 | FINANCIERE DE TUBIZE SA | N/A | Feb 2026 | 91,587 | $24.5M | 1.62% | EC |
| 17 | BIONTECH SE | 09075V102 | Feb 2026 | 132,653 | $14.6M | 0.96% | EC |
| 18 | MERCK KGAA | N/A | Feb 2026 | 94,700 | $14.3M | 0.95% | EC |
| 19 | BIOGEN INC | 09062X103 | Feb 2026 | 73,000 | $14.0M | 0.92% | EC |
| 20 | OCULAR THERAPEUTIX INC | 67576A100 | Feb 2026 | 1,331,717 | $11.9M | 0.79% | EC |
| 21 | BEAM THERAPEUTICS INC | 07373V105 | Feb 2026 | 415,400 | $11.8M | 0.78% | EC |
| 22 | XENON PHARMACEUTICALS INC | 98420N105 | Feb 2026 | 268,600 | $11.6M | 0.77% | EC |
| 23 | UNIQURE N.V. | N/A | Feb 2026 | 705,578 | $11.0M | 0.73% | EC |
| 24 | CAPRICOR THERAPEUTICS INC | 14070B309 | Feb 2026 | 389,900 | $10.9M | 0.72% | EC |
| 25 | PTC THERAPEUTICS INC | 69366J200 | Feb 2026 | 155,600 | $10.6M | 0.70% | EC |
| 26 | KYMERA THERAPEUTICS INC | 501575104 | Feb 2026 | 102,000 | $9.3M | 0.61% | EC |
| 27 | PHIBRO ANIMAL HEALTH CORP | 71742Q106 | Feb 2026 | 150,755 | $8.2M | 0.54% | EC |
| 28 | AXSOME THERAPEUTICS INC | 05464T104 | Feb 2026 | 48,900 | $8.0M | 0.53% | EC |
| 29 | ANNEXON INC | 03589W102 | Feb 2026 | 1,264,100 | $7.1M | 0.47% | EC |
| 30 | ASCENDIS PHARMA A/S | 04351P101 | Feb 2026 | 24,400 | $5.7M | 0.38% | EC |
| 31 | CORCEPT THERAPEUTICS INC | 218352102 | Feb 2026 | 158,100 | $5.6M | 0.37% | EC |
| 32 | AGOMAB THERAPEUTICS SA | N/A | Feb 2026 | 332,858 | $5.3M | 0.35% | EC |
| 33 | INTELLIA THERAPEUTICS INC | 45826J105 | Feb 2026 | 384,500 | $5.3M | 0.35% | EC |
| 34 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Feb 2026 | 122,800 | $5.0M | 0.33% | EC |
| 35 | Fidelity Revere Street Trust | 31635A105 | Feb 2026 | 4,809,384 | $4.8M | 0.32% | STIV |
| 36 | HARMONY BIOSCIENCES HOLDINGS INC | 413197104 | Feb 2026 | 158,577 | $4.5M | 0.30% | EC |
| 37 | ARROWHEAD PHARMACEUTICALS INC | 04280A100 | Feb 2026 | 65,400 | $4.1M | 0.27% | EC |
| 38 | WAVE LIFE SCIENCES LTD | N/A | Feb 2026 | 296,800 | $4.1M | 0.27% | EC |
| 39 | VERA THERAPEUTICS INC | 92337R101 | Feb 2026 | 100,700 | $4.1M | 0.27% | EC |
| 40 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Feb 2026 | 257,800 | $3.9M | 0.26% | EC |
| 41 | DISC MEDICINE INC | 254604101 | Feb 2026 | 53,800 | $3.6M | 0.24% | EC |
| 42 | DEFINIUM THERAPEUTICS INC | 24477V105 | Feb 2026 | 188,000 | $3.3M | 0.22% | EC |
| 43 | IDORSIA LTD | N/A | Feb 2026 | 639,660 | $3.3M | 0.21% | EC |
| 44 | SUMMIT THERAPEUTICS INC | 86627T108 | Feb 2026 | 169,304 | $2.8M | 0.19% | EC |
| 45 | EDGEWISE THERAPEUTICS INC | 28036F105 | Feb 2026 | 83,600 | $2.5M | 0.17% | EC |
| 46 | ARRIVENT BIOPHARMA INC | 04272N102 | Feb 2026 | 107,000 | $2.5M | 0.16% | EC |
| 47 | VIKING THERAPEUTICS INC | 92686J106 | Feb 2026 | 64,300 | $2.2M | 0.14% | EC |
| 48 | PARAGON BIOSCIENCES EMALEX CAPITAL INC | N/A | Feb 2026 | 158,879 | $1.5M | 0.10% | EP |
| 49 | CASTLE CREEK BIOSCIENCES INC | N/A | Feb 2026 | 6,308 | $1.4M | 0.09% | EP |
| 50 | EVOZYNE INC | N/A | Feb 2026 | 1,009,196 | $1.2M | 0.08% | DBT |
| 51 | EVOZYNE INC | N/A | Feb 2026 | 56,643 | $960K | 0.06% | EP |
| 52 | PARAGON BIOSCIENCES EMALEX CAPITAL INC | N/A | Feb 2026 | 22,477 | $197K | 0.01% | EP |
| 53 | PARAGON BIOSCIENCES EMALEX CAPITAL INC | N/A | Feb 2026 | 15,977 | $150K | 0.01% | EP |
| 54 | AGOMAB THERAPEUTICS SA | 00860C102 | Feb 2026 | 9,100 | $146K | 0.01% | EC |
| 55 | EVOZYNE INC | N/A | Feb 2026 | 5,900 | $97K | 0.01% | EP |
| 56 | CASTLE CREEK BIOSCIENCES INC | N/A | Feb 2026 | 200 | $51K | 0.00% | EP |
| 57 | PARAGON BIOSCIENCES EMALEX CAPITAL INC | N/A | Feb 2026 | 4,581 | $47K | 0.00% | EP |
| 58 | CASTLE CREEK BIOSCIENCES INC | N/A | Feb 2026 | 85 | $17K | 0.00% | EP |
| 59 | IONIS PHARMACEUTICALS INC | 462222100 | Feb 2026 | 100 | $8K | 0.00% | EC |
| 60 | MEDAVAIL HOLDINGS INC | N/A | Feb 2026 | 66 | $0 | 0.00% | EC |